Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Psychotic Disorders

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Psychotic Disorders in 1 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research Excerpts

ExcerptRelevanceReference
"Consecutive cases from the Alzheimer's Disease Research Center brain bank, neuroleptic free for at least 1 month prior to death, with neuropathologic diagnoses of AD with LB (AD + LB, n = 14), AD without LB (AD, n = 13), or normal brains (n = 8)."1.31Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. ( DeKosky, ST; Hamilton, RL; Healy, MT; Henteleff, R; Lewis, DA; Pollock, BG; Sweet, RA; Wisniewski, SR, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sweet, RA1
Hamilton, RL1
Healy, MT1
Wisniewski, SR1
Henteleff, R1
Pollock, BG1
Lewis, DA1
DeKosky, ST1

Other Studies

1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Psychotic Disorders

ArticleYear
Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis.
    Archives of neurology, 2001, Volume: 58, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Benzazepines; Case-Control Studies; Corpus Striatum; Dop

2001